Number of Shares
1.70 Mil
Current Holdings Value*
$64.06 Mil
% of Portfolio
2.93%
Total Estimate Gain
$-89.63 Mil
% of Total Estimate Gain
-48.05%

Paradigm Biocapital Advisors LP's Vaxcyte Inc Holding Summary

As of 2025-03-31, Paradigm Biocapital Advisors LP held 1.70 Mil shares of Vaxcyte Inc(PCVX), totaling $64.06 Mil. This investment constitutes 2.93% of their stock portfolio, and Paradigm Biocapital Advisors LP now holds 1.32% of the outstanding Vaxcyte Inc(PCVX) stock.

The initial trade took place in 2024Q1. And since then Paradigm Biocapital Advisors LP has made 4 purchases of PCVX, at an average price of $80.78, for a total of 2.31 Mil shares. In addition, there have been 1 sales at an average price of $68.07 for 612,793.00 shares. Based on historical transaction data and PCVX's current price of $32.54, Paradigm Biocapital Advisors LP's estimated gain on his PCVX holdings is $-89.63 Mil, reflecting a -48.05% gain to date.

Paradigm Biocapital Advisors LP PCVX ($32.54) Holding Chart

Paradigm Biocapital Advisors LP PCVX ($32.54) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1